Skip to main content

Featured

FS visits biomedical firm in UK

Financial Secretary Paul Chan yesterday visited a biopharmaceutical company and the Royal College of Art, and attended a lunch hosted by the China-Britain Business Council, as part of his ongoing trip to London.   Mr Chan visited AstraZeneca and met the company’s senior management to learn about its drug research and development activities, as well as its latest expansion plans.   AstraZeneca indicated that following in-depth talks with Hong Kong’s Office for Attracting Strategic Enterprises, it plans to develop a research and development centre in Hong Kong and will engage in further discussion with relevant government departments on the matter.   The Financial Secretary then attended a roundtable luncheon held by the China-Britain Business Council, and met representatives of British enterprises that do business, or plan to do business, either in the Mainland or Hong Kong.   Mr Chan later visited the Royal College of Art, which collaborated with the Hong Kong Polytechnic Unive
Read more

6 imported virus cases found

The Centre for Health Protection today said it is investigating six additional COVID-19 cases, all of which are imported.   Five of the new cases involve mutant strains and the mutation test result of the remaining case is pending.   Among the six patients, aged 30 to 69, four arrived in Hong Kong from high-risk places while the others were from medium-risk places.   Five of them tested positive for the virus during quarantine, including one patient who is a close contact of a previous imported case.   The remaining patient, a close contact of another three previous imported cases, tested positive at a hospital where he accompanied one of the infected people.   A total of 60 cases were reported in Hong Kong in the past 14 days, all of which are imported.   For information and health advice on COVID-19, visit the Government's dedicated webpage.
http://dlvr.it/SB84Tj

Popular Posts